“Based on our preliminary data, we estimate that DNA testing could reduce adverse drug reactions by 30%, saving the NHS up to ...

A person's "bioenergetic age"-or how youthfully their cells generate energy-might be a key indicator of whether they're at risk of developing Alzheimer's disease, new research from Weill Cornell ...

Discover the potential of tobacco as a future medicine and its historical applications in treating various illnesses.

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy. Male patients infrequently live ...

Integrating genomics and biomarkers into kidney transplantation practices offers a promising route to more personalized and predictive medicine. By adapting treatments to individual needs, this ...

Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...

Stay up to date on the work of researchers in NYU Langone’s Center for Human Genetics and Genomics by reading the latest news ...

Genalive, a joint venture of BGI Genomics, has secured a three-year centralized procurement project for outsourced testing ...

The Genes, Systems and Computation Seminar (GSC) series is jointly run by the Institute for Systems Genetics (ISG) and the ...

Medium and high type 2 diabetes (T2D) genetic risks are not associated with an increased risk for atherosclerotic ...

University of California San Diego School of Medicine is pleased to announce that Tariq Rana, Ph.D., Distinguished Professor ...